Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus)
- PMID: 17183154
- DOI: 10.3233/jad-2006-10411
Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus)
Abstract
Recent studies from our laboratories and others suggest that calorie restriction (CR) may benefit Alzheimer's disease (AD) by preventing amyloid-beta (Abeta) neuropathology in the mouse models of AD. Moreover, we found that promotion of the NAD+-dependent SIRT1 mediated deacetylase activity, a key regulator in CR extension of life span, may be a mechanism by which CR influences AD-type neuropathology. In this study we continued to explore the role of CR in AD-type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). Monkeys were maintained on the normal and CR diets throughout the entire lifespan until they died of natural causes. We found that 30% CR resulted in reduced contents of Abeta1-40 and Abeta1-42 peptides in the temporal cortex of Squirrel monkeys, relative to control (CON) fed monkeys. The decreased contents of cortical Abeta peptide inversely correlated with SIRT1 protein concentrations in the same brain region; no detectable change in total full-length amyloid-beta protein precursor (AbetaPP) level was found. Most interestingly, we found that 30% CR resulted in a select elevation of alpha- but not beta- or gamma- secretase activity which coincided with decreased ROCK1 protein content in the same brain region, relative to CON group. Collectively, the study suggests that investigation of the role of CR in non-human primates may provide a valuable approach for further clarifying the role of CR in AD.
Similar articles
-
Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction.J Biol Chem. 2006 Aug 4;281(31):21745-21754. doi: 10.1074/jbc.M602909200. Epub 2006 Jun 2. J Biol Chem. 2006. PMID: 16751189
-
Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.FASEB J. 2004 May;18(7):902-4. doi: 10.1096/fj.03-0978fje. Epub 2004 Mar 19. FASEB J. 2004. PMID: 15033922
-
Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice.Neurobiol Aging. 2015 Mar;36(3):1293-302. doi: 10.1016/j.neurobiolaging.2014.10.043. Epub 2014 Dec 4. Neurobiol Aging. 2015. PMID: 25556162 Free PMC article.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease.J Alzheimers Dis. 2015;45(2):329-47. doi: 10.3233/JAD-142730. J Alzheimers Dis. 2015. PMID: 25589722 Review.
Cited by
-
A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegeneration.J Neurosci. 2013 May 22;33(21):8951-60. doi: 10.1523/JNEUROSCI.5657-12.2013. J Neurosci. 2013. PMID: 23699506 Free PMC article. Clinical Trial.
-
BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.Neurochem Res. 2010 Feb;35(2):181-210. doi: 10.1007/s11064-009-0054-1. Epub 2009 Sep 17. Neurochem Res. 2010. PMID: 19760173 Review.
-
Disentangling Mitochondria in Alzheimer's Disease.Int J Mol Sci. 2021 Oct 26;22(21):11520. doi: 10.3390/ijms222111520. Int J Mol Sci. 2021. PMID: 34768950 Free PMC article. Review.
-
Sirtuins, bioageing, and cancer.J Aging Res. 2011;2011:235754. doi: 10.4061/2011/235754. Epub 2011 Jun 30. J Aging Res. 2011. PMID: 21766030 Free PMC article.
-
Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders.Exp Neurol. 2011 Nov;232(1):1-6. doi: 10.1016/j.expneurol.2011.08.014. Epub 2011 Aug 30. Exp Neurol. 2011. PMID: 21907197 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical